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ABSTRACT 
SHIAHNA M. DYE: Factors Affecting the Impact of Breast Cancer on Body Image and 
Sexual Functioning 
(Under the direction of Donald Baucom, Ph.D.) 
 
 
The diagnosis and treatment of breast cancer impacts a woman on many levels. 
Women often experience a wide range of psychological and sexual difficulties. The 
psychosocial and psychosexual impact of this disease is influenced by a number of factors 
including medical factors, individual factors, and relationship factors. Overall, breast cancer 
treatments (medical factors) did not disrupt sexual functioning or body image. Instead, 
depression and fatigue (individual factors) were found to impact women’s sexual 
functioning, and depression was related to women’s own body image as well as how she 
perceived her male partner to view her body. Lastly, women’s perceptions of their male 
partners’ view of their bodies (relationship factor) were related to the women’s own body 
image and marital satisfaction. Results suggest a more optimistic view regarding the 
anticipated negative consequences of a breast cancer diagnosis.   
 
 
 
 
 
iii 
This is dedicated in memory of my loving father who instilled in me the value of an 
education and unwavering faith. “Then Jesus told them, ‘I assure you, if you have faith and 
don’t doubt, you can do things like this and much more (Matthew 21:21).”  
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FACTORS AFFECTING THE IMPACT OF BREAST CANCER ON BODY IMAGE AND 
SEXUAL FUNCTIONING 
The diagnosis and treatment of breast cancer impacts a woman on many levels. 
Women often experience a wide range of psychological and sexual difficulties. The 
psychosocial and psychosexual impact of this disease is influenced by a number of factors. 
For the current study, these factors will be separated into three categories: medical factors, 
individual factors, and relationship factors in order to explore their impact on body image 
and sexual functioning. Medical factors include various aspects of the treatment process 
including surgical and other medical treatments. Individual factors pertain to physical and 
psychological elements such as pain, fatigue, depression, and anxiety. Lastly, relationship 
factors consist of the interpersonal aspects of the couple’s relationship as viewed both by the 
women with breast cancer and their partners. 
The Impact of Medical Factors on Body Image and Sexual Functioning in Women with 
Breast Cancer 
 
Women with breast cancer are faced with a number of options and considerations 
concerning their treatment process. These options, however, often come with a price; some 
are more costly than others. These treatment considerations include the type of surgical 
treatment performed; the option of breast reconstruction; and type of post surgical treatment 
such as chemotherapy (occasionally offered prior to surgery).  
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The principal surgical treatments for breast cancer are lumpectomy (breast-
conservation) and mastectomy.  Both treatments have similar survival rates, so the choice of 
treatment often rests largely on the differential impact of the two treatment options on 
physical and psychological well-being (King, Kenny, Shiell, Hall, & Boyages, 2000).  
Because each surgical treatment physically alters the breast which in American culture 
embodies femininity, womanhood, sexuality, attractiveness, nurturance, and motherhood 
(Pikler & Winterowd, 2003), women’s views of their bodies are likely altered as a function 
of the surgery they receive.   
Research has typically found that women who have undergone breast-conserving 
surgery demonstrate more positive body images than women who have had mastectomies for 
the treatment of breast cancer.  More specifically, women with breast-conserving surgery are 
less likely to experience feelings of loss, become self-conscious about body presentation, or 
experience significant changes in body ideal, and are more likely to retain perceptions of 
physical attractiveness and femininity when compared with women who have undergone 
mastectomies (Engel et al., 2004; King et al., 2000; Steinberg, Juliano, & Wise, 1985). The 
greater disruption of the sense of femininity and sexual desirability among mastectomy 
patients is seen as a reaction to the greater disfigurement of the more extensive surgery.   
Often accompanying the type of surgical intervention undertaken is the choice of 
breast reconstruction.  This option is widely assumed to offer psychological benefits to 
women treated by mastectomy for breast cancer.  Levels of satisfaction with body image for 
women who undergo reconstruction are reported to fall in between those women treated with 
mastectomy without reconstruction and those receiving breast-conserving treatment (Mock, 
1993; Wellisch et al., 1989). 
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When exploring the effects of surgical treatment type on sexual functioning, however, 
results have not been as conclusive. The more widespread practice of breast-conserving 
surgical treatment in comparison to mastectomy was expected to diminish the negative 
impact of treatment on sexual functioning. Unfortunately, this goal has not been fully 
realized.  Several studies have shown no difference in sexual functioning for breast cancer 
survivors on the basis of surgical treatment (Ganz, 1997; Levy et al., 1992; Kiebert, de Haes, 
& van de Velde, 1991) whereas others find that women who have breast-conserving surgery 
report better sexual functioning (Meyer & Aspegren, 1989; Steinberg et al., 1985). Thus, the 
impact of breast preservation and reconstruction in preventing and ameliorating sexual 
problems in cancer patients is subtle at best (Schover, 1997) and appears to protect only 
women’s perception of their body but does not contribute to a more positive sexual 
adjustment (Schain et al., 1994).   
Another aspect of the treatment process that has been examined is the type of 
postoperative (or preoperative) treatment received.  Women with breast cancer may receive 
chemotherapy, antiestrogenic therapy (e.g., tamoxifen), or both. Chemotherapy use has been 
shown to be a predictor of poor sexual functioning (Ganz et al., 1996) with women reporting 
vaginal dryness, decreased libido, dyspareunia (painful intercourse), and difficulty reaching 
orgasm (Young-McCaughan, 1996). Even up to five years posttreatment, sexual problems 
remain more common in women treated with chemotherapy (Ganz et al., 1998).    
The Impact of Individual Factors on Body Image and Sexual Functioning in Women with 
Breast Cancer 
 
In addition to the medical treatments that women receive, there are also individual 
factors that play a role in the impact of breast cancer on body image and sexual functioning.  
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These factors include physical experiences such as pain and fatigue as well as psychological 
features including depression and anxiety.   
As a result of the aforementioned treatments, breast cancer patients are more 
susceptible to physical symptoms such as pain and fatigue. Chronic localized or regional pain 
thought to result from damaged nerves (Elliot & Folley, 1989) is common after breast cancer 
surgery with prevalence rates ranging from 20-27% (Stevens, Dibble & Miaskowski, 1995). 
In addition to pain experienced in the breast area, women with breast cancer also experience 
pain or discomfort in the vaginal area during sex.  Because these women experience 
symptoms such as poor vaginal lubrication and vaginal atrophy, sex is often painful or 
uncomfortable which results in an avoidance of sexual activity.  Thus, since pain appears to 
be quite common and pervasive in this particular group of women, irrespective of its 
location, it is a salient factor in the relationship between breast cancer and declining sexual 
functioning. 
Fatigue is another symptom that is common to breast cancer patients that is often 
found to co-occur with pain and has been implicated as a major hindrance of sexual pleasure 
(Winningham, 1994). Posttreatment breast cancer survivors, who had previously received 
chemotherapy as a part of their treatment, appear to be more likely to report more severe and 
persistent fatigue in comparison to healthy women in a similar reference group or other 
breast cancer survivors who did not receive chemotherapy as a part of their treatment (Bower 
et al., 2000). However, fatigue may not only be due to the cancer treatment, but also due to 
the cancer itself, and may persist after treatment has been completed, even in those patients 
who are felt to be cancer free (Nail, 2002).  
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Recent studies have consistently found high rates of fatigue in breast cancer patients 
lasting months to years after treatment. Investigators suggest that this pervasive problem is 
unlikely to be accounted for by treatment effects and propose further investigation of the 
close relationship between post-cancer fatigue and diagnoses of depression and anxiety 
(Bower et al., 2006; Nieboer et al., 2005; Young & White, 2006). Goldstein et al. (2006) 
longitudinally investigated the relationship between fatigue and mood disorder in a sample of 
women with breast cancer and found mood disorder to be the only significant predictor of 
fatigue. Results further indicated that fatigue was relatively stable over time but was unlikely 
to evolve into a mood disorder, suggesting that the two symptoms have independent 
determinants yet still frequently accompany one another.        
 Irrespective of fatigue, studies have shown that depression and anxiety are prevalent 
in cancer patients. In breast cancer patients, Kissane et al. (1998) noted that up to 45% of 
early stage breast cancer patients had anxiety or depression or both. Women reported feeling 
less attractive, experiencing significant stress concerning hair loss or weight gain, and many 
reported losing interest in sex. Even within the general population, depression and anxiety in 
women are often associated with an increase in female sexual dysfunction (Henson, 2002). 
Therefore, for breast cancer patients who are experiencing a host of other symptoms and 
concerns (e.g., performance anxiety, fear or pain or discomfort during sex) that compromise 
their sexual functioning (i.e., sexual excitement, arousal, and orgasm) in addition to 
depression and anxiety, the impact of these psychological problems can only serve to 
magnify a potentially devastating blow to their sexuality.      
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The Impact of Relationship Factors on Body Image and Sexual Functioning in Women with 
Breast Cancer 
 
In addition to medical factors and individual factors, there are also relationship 
factors that play a role in how breast cancer affects a woman’s sexual functioning and body 
image. Northouse et al. (1998) found that when one partner has a serious illness, both 
partners in an intimate relationship experience distress, and this distress in turn can adversely 
affect their sexual relationship.  Partners are viewed as essential sources of support for 
women during this difficult time, and their partners’ responses are critical to the women’s 
adjustment.  For example, Wimberly et al. (2005) found that perceived partner emotional 
involvement, perceived partner sexual interest, and perceived partner negative reaction to 
surgical scars to be predictors of women’s psychosexual adjustment after breast cancer.  
Perceived partner emotional involvement and perceived partner sexual interest were also 
predictive of marital satisfaction for women. Conversely, Wai Ming (2002) found that 
partners’ lack of social support and disruption of sexual relationship by breast cancer 
treatment were factors leading to an increase in marital problems. 
In addition to the physical effects experienced as a result of breast cancer, there are 
psychological effects in the form of body image concerns that can inhibit sexual functioning 
for both partners.  Body image concerns are amplified in women with breast cancer as a 
result of their perceived disfigurement to a body part associated with femininity and 
sexuality.  Her body image concerns can be further increased if the woman perceives her 
partner as negatively reacting to her new physical form.  Wai Ming (2002) found that 
perceived partner evaluation of her physical appearance was a better predictor of her marital 
satisfaction than was her own negative body image.  Thus, it appears that if a woman is 
uncomfortable with her body or perceives that her partner does not like the way she looks, 
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she may then withdraw sexually which impacts the couple’s sexual relationship again as a 
pattern of withdraw and avoidance develops.  
Overall, studies suggest that perceived partner reactions play an integral role in the 
couple’s psychosexual response to the diagnosis and treatment of breast cancer which 
warrants further investigation.   
In order to further elucidate the relationship among breast cancer, body image, and 
sexual functioning, the current study seeks to explore these relationships by first 
investigating the overall affects of chemotherapy and surgery on sexual functioning and body 
image. It has been demonstrated that chemotherapy affects sexual functioning and that 
surgery affects body image, but are there other mechanisms through which this occurs? It is 
possible that these are direct and straightforward relationships; however it is also likely that 
there are other factors that could further explain the relationships among these variables. 
Additionally, the relationship among the aforementioned factors and sexual functioning and 
body image will be explored. Thus, the following four hypotheses are posited. 
It is hypothesized that (1) chemotherapy will be associated with level of sexual 
functioning. More specifically, women treated with chemotherapy will experience lower 
levels of sexual functioning than women not receiving chemotherapy. Additionally, 
chemotherapy can have a number of physical affects on the body including pain and fatigue, 
which have also been implicated as major hindrances to sexual functioning (Winningham, 
1994). Thus, it appears that the impact that chemotherapy has on sexual functioning can be 
partially attributed to the physical affects of pain and fatigue.  
The prevalence of psychological disorders, particularly symptoms of depression and 
anxiety, in cancer patients is high (Derogatis et al., 1983). Depression results from feelings of 
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loss, and anxiety is experienced in response to feelings of not knowing what will happen 
next. After chemotherapy, women experience a number of losses including a loss of hair and 
a loss of skin, etc. Additionally, they may experience anxiety about their future which could 
include more treatments and cancer reoccurrence. Thus, undergoing chemotherapy might 
also impact sexual functioning through the woman’s experience with anxiety and depression.  
In sum, it is expected that the relationship between chemotherapy and sexual functioning will 
be partially mediated by two prominent physical symptoms, pain and fatigue, and two mood 
symptoms, depression and anxiety.  
Further, given the effects of chemotherapy on estrogen in younger women, this 
relationship is predicted to be moderated by age such that younger women who have had 
chemotherapy treatment are expected to be affected more in their sexual functioning than 
older women.  
Research has generally found that women with breast-conserving surgery 
demonstrate more positive body images than women with mastectomies as a result of the 
decreased likelihood of feelings of loss or self-consciousness and the retention of feelings of 
attractiveness and femininity.  Research has been inconclusive regarding the assumed 
benefits of mastectomy with reconstruction on body image. Regarding the effect of surgical 
treatment on sexual functioning, overall, studies have shown no difference in sexual 
functioning for breast cancer survivors on the basis of surgical treatment (Ganz, 1997; Levy 
et al., 1992; Kiebert, de Haes, & van de Velde, 1991).  Therefore, it is predicted that (2) type 
of surgical treatment will be associated with level of body image, but not with level of sexual 
functioning.  More specifically, women with lumpectomies are predicted to have more 
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positive body images, followed by women with mastectomies with reconstruction, and lastly 
women with mastectomies alone.    
In general, surgery is expected to impact a woman’s body image. However, it seems 
plausible that depression and anxiety could further explain how the relationship between 
surgery and body image operates. Once a woman undergoes surgery, they may experience 
feelings of loss about their altered breasts and feelings of anxiety about how they will look 
afterwards and even if their new bodies will be accepted by their partners. The logic follows 
that the impact of surgery on a woman’s body image could occur through her experiences 
with depression and anxiety. Therefore, it is predicted that the relationship between surgery 
and body image will be partially mediated by depression and anxiety.  
 It is logical to assume that in general, if a woman has a good body image that she 
would have higher levels of sexual functioning.  However, for women diagnosed with breast 
cancer, there does not seem to be a relationship between these two variables, or the 
relationship is inconsistent across studies.  This finding would suggest that there is some 
additional variable which is unaccounted for that impacts the relationship between body 
image and sexuality.  One such moderating factor is likely to be chemotherapy.  More 
specifically, for women who have undergone chemotherapy treatment, body image is not 
predicted to be related to sexual functioning because even if these women do have more 
positive body images, they may still have lower levels of sexual functioning as a result of the 
physiological effects of chemotherapy treatment.  However, among women not receiving 
chemotherapy, body image and sexual functioning would be expected to be correlated.  
Consistent with this perspective, it is posited (3) that the relationship between body image 
and sexual functioning will be moderated by chemotherapy status.  In particular, body image 
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and sexual functioning will be positively associated in women who did not undergo 
chemotherapy treatment.  In contrast, body image and sexual functioning are hypothesized 
not to be correlated among women who received chemotherapy. 
Finally, it is predicted that (4) women’s perceptions of how their partners view them 
will be associated with the women’s own marital satisfaction as well as with the women’s 
body image. Findings suggest that among women with breast cancer, the females’ 
perceptions of their male partners’ reaction to her breast cancer strongly influence the 
women’s adjustment over time (Wai Ming, 2002).  Thus, it is expected that more positive 
perceptions of how women believe their male partners view the women will be associated 
with higher levels of the women’s own marital satisfaction as well as higher levels of the 
women’s own body image.  
Method 
Participants 
 Participants were 134 couples in which the women had been recently diagnosed with 
early-stage breast cancer.  These participants were part of a larger study focused on treating 
heterosexual couples in which the female had breast cancer.  Participants were recruited at 
the University of North Carolina (UNC) Hospital, Duke University Medical Center, and 
various cancer clinics in the same geographic area.  Women were eligible to participate if the 
following criteria had been met: (1) they had been diagnosed with Stage I, II, or IIIa breast 
cancer within one calendar year of the recruitment date, and their diagnosis had never 
exceeded Stage IIIa, (2) they had no prior history of breast cancer unless it occurred in the 
past year in which the invasive cancer was diagnosed, (3) they had not had any form of 
cancer (except basal cell carcinoma) within the past five years, (4) the woman and her male 
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partner were married or had lived together in a committed relationship for at least 12 months, 
(5) both the woman and her partner were willing to participate, and (6) both partners spoke 
English. 
 In order to determine if a woman was eligible for the study, the research team first 
reviewed potential participants’ medical records.  For women who met inclusion criteria, a 
letter from the attending physician was sent to the women, briefly informing them about the 
study.  Then, each woman was approached by members of the research team during her next 
appointment at the breast clinic at UNC Hospitals or at the Duke University Medical Center.  
The team provided the woman with information about the study along with a brochure and 
asked the woman to complete a form allowing the research team to contact her about 
participating in the study.  If the research team was unable to meet with the woman at her 
appointment, the research team contacted her by telephone in order to describe the study.  
These procedures were approved by UNC’s and Duke’s Institutional Review Board. 
Procedure 
As part of a larger study (see Baucom et al., 2005 for details), participants were 
recruited as described above.  Following recruitment, participants and their partners 
completed an initial assessment session, consisting of a number of baseline questionnaires, 
which included demographic data and background characteristics of the participants that 
were utilized in the present study, and video-taped interaction tasks.  The couples were then 
be randomly assigned to one of three experimental conditions (i.e., Cancer-Focused 
Relationship Enhancement, a couple-based cognitive behavioral therapy with a focus on 
cancer-related issues; couple-based Cancer Education, in which couples received medical 
information about breast cancer; or Treatment-as-Usual, in which couples received written 
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materials about breast cancer and a list of community resources).  The couples received $40 
for completing the initial assessment session.   
The present study will focus on measures, described in the next section, completed by 
the participants during the initial assessment. 
 Materials 
Derogatis Interview for Sexual Functioning -Self Report (DISF-SR; Derogatis & 
Melisaratos, 1979).  Sexual adjustment was measured with a 25-item inventory that assesses 
five aspects of sexual experiences including sexual cognition/fantasy, sexual arousal, sexual 
behavior/experiences, orgasm, and sexual drive/relationship during the last 30 days.  Sexual 
cognition/fantasy, sexual arousal, and sexual behavior/experiences were measured with five 
items, rated on an 9-point scale from 0 (“not at all”) to 8 (“4 or more per day”).  The last two 
items assessing sexual arousal were rated on a 5-point scale from 0 (“never”) to 4 (“always”).  
Orgasm was measured with six items rated on a 5-point scale from 0 (“never”) to 4 
(“always”).   Sexual drive/relationship was measured with four items. The first item was 
measured on a 9-point scale from  0 (“not at all”) to 8 (“4 or more per day”). The other three 
items were rated on a 5-point scale from 0 (“not at all”) to 4 (“extremely”).Reliability and 
validity of the DISF have been well established, with the majority of research focusing on 
sexually dysfunctional patients and non-patient comparison participants (Derogatis & Meyer, 
1979; Derogatis, Meyer, & Dupkin, 1976). Test-retest reliability coefficients for the 10 
domain scores range from .61 (Information) to .96 (Attitude), with internal consistency 
coefficients ranging from .56 (Information) to .97 (Experience) (Derogatis & Melisaratos, 
1979).     
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Quality of Marriage Index (QMI; Norton, 1983).  Relationship satisfaction was 
measured with six items (i.e., “Circle the number corresponding to your relationship in the 
past week.”), rated on a 7-point scale from 1 (“very strong disagreement”) to 7 (“very strong 
agreement”). The last item (i.e., “Circle the number that best describes the degree of 
happiness, everything considered, in your marriage or relationship.”) was rated on a 10-point 
scale from 1 (“very unhappy”) to 10 (“very happy”).  Scores range from 6-45 with higher 
scores indicating higher levels of satisfaction. Prior research has shown that the QMI has 
excellent reliability (α = .97) and convergent and discriminative validity, correlating highly 
with other self-report measures of marital satisfaction (Heyman, Sayers, & BellacK, 1994).   
Self-Image Scale (SIS; Halford, Scott, & Smythe, 2001).  Body image adjustment was 
measured with eleven items from the Self-Image Scale that was designed specifically for 
women with cancer.  There are two scales: Self-Acceptance, comprising six items that assess 
acceptance of appearance and sense of femininity (e.g., “I feel attractive.”), and Partner 
Acceptance, comprising five items that assesses women’s perceptions of their partners’ 
acceptance of their appearance (e.g., “I think my partner finds me attractive.”).  This measure 
is rated on a 5-point scale ranging from 1 (“strongly disagree”) to 5 (“strongly agree”).  
Scores range from 10-50 with higher scores indicating better self-image.  Intrascale 
reliabilities are high, with alphas ranging from .83 to .92 for Self Acceptance and from .82 to 
.91 for Partner Acceptance (Scott, Halford, & Ward, 2004).   
Brief Symptom Inventory-18 (BSI-18; Derogatis, 2000).  Psychological distress (i.e., 
anxiety and depression) was measured with an 18-item inventory that assesses their levels of 
distress.  These items are rated on a 5-point scale ranging from 0 (“not at all”) to 4 
(“extremely”).  Higher scores indicate more distress.  The total score of the BSI-18 has been 
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reported to have a reliability of 0.89.  Evidence of its validity has also been established 
through strong correlations with the 53-item BSI and other established measures of 
psychological symptoms (Derogatis, 2000).   
Brief Fatigue Inventory (BFI; Mendoza et al., 1999). In order to assess symptoms of 
fatigue associated with cancer, participants rated ten items from the Brief Fatigue Inventory.  
These items measured tiredness in the last week, fatigue now, fatigue in the past 24 hours and 
fatigue interference in life in the last 24 hours.  Items are rated on a 10-point scale ranging 
from 1 (“no fatigue”) to 10 (“fatigue as bad as you can imagine”).  Fatigue interference is 
rated on a 10-point scale from 1 (“does not interfere”) to 10 (“completely interferes”).  
Higher scores indicate greater fatigue and fatigue interference.  Reliability for this instrument 
has been established with an internal consistency coefficient of 0.96.  Construct validity has 
been established with factor analysis with high factor loadings ranging from 0.81 for usual 
fatigue to 0.92 for activity.  Evidence of concurrent validity has also been established through 
its strong correlations with the fatigue subscales of the Functional Assessment of Cancer 
Therapy (FACT) and Profile of Mood States (POMS).  Lastly, discriminant validity was 
established by comparing BFI scores of patient groups who were expected to have differing 
levels of fatigue (Mendoza et al., 1999).          
Brief Pain Inventory (BPI; Cleeland & Ryan, 1994).  In order to assess pain 
associated with cancer, participants rated two items from the Brief Pain Inventory that asked 
participants to rate their usual and worst cancer pain in the last week.  This item is rated on a 
10-point scale ranging from 1 (“no pain”) to 10 (“pain as bad as you can imagine”).  Higher 
scores indicate greater pain.  The Brief Pain Inventory has demonstrated both reliability and 
validity across cultures and languages and has been adopted widely in studies of 
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effectiveness of pain management, with coefficient alphas ranging from 0.78 to 0.97 
(Cleeland & Ryan, 1994).      
Results 
Sample Characteristics 
A total of 134 women participated in the study. The mean age of participants was 
52.9 years (SD=11.6) with a range from 29 to 82; 85% were Caucasian, 10% were African-
American, 3% were Asian, and 2% were Hispanic. Women were married for an average of 
23.6 years (SD=14.2) with 40.3% having an average family income between $100,000 and 
$249,999. The average number of years of education was 16.4 (SD=2.9).  
When breast cancer treatment was considered, 32% had been treated with 
chemotherapy. Half of the women had lumpectomies, 26% had mastectomies without 
reconstruction, 9% had mastectomies with reconstruction, and 14% did not have surgery.    
Predictors Relating to Sexual Functioning 
It was predicted that chemotherapy would be associated with level of sexual 
functioning such that women who were treated with chemotherapy would be expected to 
experience lower levels of sexual functioning than women who did not receive 
chemotherapy. Additionally, this relationship was predicted to be moderated by age and 
partially mediated by depression, anxiety, pain, and fatigue. A paired samples t-test was 
conducted to evaluate this relationship. As shown in Table 1, overall the women 
demonstrated a somewhat low level of sexual functioning relative to a nonpatient population 
(Derogatis, 1997); however, no significant differences were found in sexual functioning 
based on chemotherapy status. Because no significant differences were found overall, no 
mediation is possible. However, in order to gain further understanding of the relationships 
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among these variables, standard regressions were conducted (see Table 2). Although the 
overall models were not supported, depression and fatigue were found to predict sexual 
drive, arousal, and orgasm such that women who experienced higher levels of depression and 
fatigue reported lower sex drives, lower levels of arousal, and lower satisfaction with their 
orgasms. In addition, regressions were conducted to test for moderation of age.  As shown in 
Table 2, there was no moderation of age; that is, chemotherapy did not have a differential 
effect on sexual functioning for younger women. 
Additionally, it was expected that type of surgical treatment would not be associated 
with level of sexual functioning. A One-way ANOVA was conducted and confirmed that 
there were no significant differences in sexual functioning based on surgical status.  
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Table 1 
Means and Standard Deviations of Sexual Functioning Measure by Chemotherapy Status 
Sexual 
Functioning 
Chemotherapy Standard 
Score* 
Mean Standard 
Deviation 
     
Sexual Cognition Yes 
No 
42 
44 
10.60 
12.76 
8.82 
8.36 
Sexual Arousal Yes 
No 
39 
39 
8.25 
8.19 
5.14 
5.54 
Sexual Behaviors Yes 
No 
39 
42 
8.30 
9.10 
5.08 
5.69 
Orgasm Yes 
No 
39 
39 
10.56 
10.77 
7.74 
7.49 
Sexual Drive Yes 
No 
40 
40 
10.65 
11.06 
4.13 
3.78 
     
* Note. Standard score based on norms for non-patient population (Derogatis, 1997). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 18 
 
Table 2 
Summary of Regression Analyses Relating Each Predictor Variable to Sexual Functioning 
 Sexual 
Cognition/Fantasy 
Sexual 
Arousal 
Sexual 
Behavior/Experiences 
Orgasm Sexual 
Drive/Relationship 
      
Depression -.075 -.208* -.172 -.302** -.280** 
Anxiety .049 -.097 -.058 -.153 -.130 
Pain .021, .113 -.079, 
.006 
-.017, .021 -.124, -
.124 
-.007, -.029 
Fatigue -.016 -.232** -.140 -.200* -.278** 
Age x 
Chemo 
-.652 .066 -.152 -.194 -.069 
 
Note.  Values are standardized regression coefficients. 
* p<.05.  ** p<.01. 
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Predictors Relating to Body Image 
It was predicted that type of surgical treatment would be associated with body image 
such that women who had not undergone surgery would have higher body image scores, 
followed by women who had breast conserving surgery, mastectomies with reconstruction, 
and lastly those who had mastectomies without reconstruction. Additionally, this relationship 
was predicted to be partially mediated by depression and anxiety. For this analysis, 
chemotherapy was coded as a 0 or a 1, and the four surgical conditions were dummy coded 
as four variables to denote whether a woman was in a category or not. None (no surgery) was 
the reference variable to which the other categories were compared. A One-way ANOVA 
was conducted and revealed no significant differences in body images scores based on 
surgical status (See Table 3). Because no significant differences were found overall, again, 
no mediation is possible. However, in order to gain further understanding of the relationships 
among these variables, standard regressions were conducted. The overall models were not 
supported, but depression was found to predict how a woman felt about her body (β= -.299, 
p=.001) as well as how she perceived her partner felt about her body (β = -.271, p<.01); that 
is, women with lower levels of depression felt better about their bodies and perceived that 
their partners felt better about their bodies.   
Additionally, it was expected that women’s perceptions of their partners’ views of 
their body would be associated with women’s own body image as well as their marital 
satisfaction. Correlational analyses show that women’s perceived partner acceptance was 
positively correlated with women’s own body image (r= .431, p<.01) and their marital 
satisfaction (r= .433, p<.01).  
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Table 3 
Means and Standard Deviations of Body Image Scores by Surgical Treatment Type 
Surgical Treatment Body Image Mean Standard Deviation 
    
None Self-Acceptance 
Partner Acceptance 
19.37 
18.28 
4.98 
4.69 
Lumpectomy Self-Acceptance 
Partner Acceptance 
21.28 
21.11 
4.81 
3.97 
Mastectomy without 
Reconstruction 
Self-Acceptance 
Partner Acceptance 
19.40 
19.57 
4.33 
4.67 
Mastectomy with 
Reconstruction 
Self-Acceptance 
Partner Acceptance 
18.25 
20.75 
5.45 
4.79 
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Relationship between Body Image and Sexual Functioning 
 The relationship between body image and sexual functioning was predicted to be 
moderated by chemotherapy status such that in women who did not undergo chemotherapy 
treatment, how they felt about their bodies would be related to how they functioned sexually. 
This relationship, however, was not expected to be maintained in women who did undergo 
chemotherapy treatment. Regression analyses were conducted to examine this relationship 
(See Table 4).The findings indicated that body image was significantly associated with 
sexual drive and experiencing orgasms such that women with higher body images had higher 
sexual drives and more satisfying orgasms. However, the results further indicated this was an 
overall effect for women, such that chemotherapy did not moderate the relationship between 
body image and sexual functioning.  
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Table 4 
Summary of Regression Analyses Relating Body Image, Chemotherapy, and Their Interaction 
to Sexual Functioning 
 Sexual 
Cognition 
Sexual 
Arousal 
Sexual 
Behaviors 
Orgasm Sexual 
Drive 
      
Body Image  .152 .247 .140 .441** .376** 
Chemotherapy -.103 .181 -.527 .391 .070 
Body Image x 
Chemotherapy 
.259 -.169 .652 -.342 .028 
 
Note.  Values are standardized regression coefficients. 
* p<.05.  ** p<.01. 
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Discussion 
This study examined the impact of breast cancer and its treatment on women’s sexual 
functioning and body image. Overall, it was found that breast cancer treatments such as 
chemotherapy and surgical treatment did not disrupt sexual functioning. In general, this 
population experienced lower levels of sexual functioning when compared to a non-patient 
population (See Table 1), but this does not seem to be attributable to breast cancer treatments 
but rather to some other factor related to the cancer experience. This finding is contrary to 
what has been found in previous studies (Ganz, 1996; Young-McCaughan, 1996) which 
report deleterious effects of chemotherapy on sexual functioning. However, these studies 
were based on the use of older chemotherapy drugs and since these drugs are steadily 
changing, it is plausible that the newer chemotherapy drugs may not have the same negative 
side effects. On the other hand, it was a woman’s mood (i.e., depression) and physical 
symptoms such as fatigue that were found to impact her sexual functioning. This finding is 
consistent with other studies that demonstrated depression and fatigue to interrupt sexual 
functioning in normal populations (Henson, 2002) as well as those with breast cancer 
(Winningham, 1994).   
This study also found that body image was not influenced by what type of surgical 
treatment a woman underwent but rather her mood impacted how she felt about her own 
body as well as how she perceived her partner felt about her body. This finding is contrary to 
what was predicted and to those studies that report improvements in or higher body images in 
women who undergo breast conserving surgery versus those who have mastectomies. 
Although there were no significant differences among the surgical groups, there was a trend 
consistent with previous findings in which women who had breast conserving surgery 
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reported slightly higher body image scores followed by women who had mastectomies 
without reconstruction and those who had not undergone surgery. 
Thus, these findings can provide hope to women that the anticipated negative 
psychological responses to surgery are not automatic and that they and their partners can still 
have positive views about the changes in their bodies regardless of the type of surgery they 
have. Furthermore, women’s perceptions of how their partners felt about their bodies were 
associated with their own body image and marital satisfaction. This demonstrates the 
importance of the male partner and how they view their female partners. This is consistent 
with other findings that demonstrate better adjustment to breast cancer among women who 
receive support and acceptance from their partners (Wimberly et al., 2005).  
Although, these results diverge from what was predicted and from what has 
previously been found in the literature, what they do provide is hope in that the negative 
consequences typically associated with breast cancer and its treatment are not automatic. 
Many women can still feel good about their bodies and maintain healthy sexual relationships 
with their partners; regardless of the treatments they receive which, overall, is good news for 
women who are diagnosed with breast cancer.      
Limitations 
Although this study contributes important findings, its limitations should be noted. 
This study was cross-sectional research and not longitudinal, so the long term effects of these 
treatments are unknown. Some of these women are still in the active stage of treatment; 
therefore, it is not certain as to how these treatments may impact the women in the long run. 
There have been longitudinal studies that have found that the negative effects of breast 
cancer treatments are persistent or worsen over time (Bower et al., 2006; Ganz et al., 1998; 
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Ganz et al., 2002; Young-McCaughan, 1996).  Thus, the promising findings from the current 
study must be viewed cautiously until the long term adaptation of these women becomes 
known.  
Another limitation of this study for interpretation is that women self-select their 
surgical conditions.  What this means is that caution is warranted in interpreting the results 
because they cannot be compared across conditions since it is unknown how women would 
have reacted if they were to have a different procedure performed. For example, if women 
who elected breast reconstruction had not received reconstruction, it is unclear how they 
might have felt about their bodies; perhaps they would have felt worse about themselves.  
Therefore, we cannot conclude that having reconstruction does not lead to more positive 
body image, although this group of women did not demonstrate significantly higher body 
images than women without reconstruction (who self-selected not to have reconstruction). 
Clinical Implications and Future Directions 
 Overall, the results of this study demonstrated that even with breast cancer treatments 
such as chemotherapy and surgery, women experience similar levels of sexual functioning 
and body images across treatment conditions. Rather, it was individual factors such as 
depression and fatigue that had association with sexual functioning and body image. 
Clinically, this suggests that in order to help women with breast cancer adjust more 
effectively, it may be most advantageous to employ strategies to help them to better cope 
with their fatigue and feelings of depression (although caution must be exercised given the 
correlational nature of the findings). Further, results suggest the importance of a woman’s 
perceptions of how her partner is reacting to her body. Thus, male partner involvement could 
also be a key component in helping women to better cope and adjust.  
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 Future research directions include further investigation of the effects of newer 
treatments on women’s psychosexual functioning and examining these effects longitudinally 
to assess their impact over time as treatment effects have been demonstrated to be maintained 
posttreatment.  
Conclusions 
 Although the results of this study were not what as anticipated, they may be 
representative of a more optimistic outlook in the breast cancer literature. This study can 
provide hope to women diagnosed with breast cancer because they do not have to assume 
that the negative consequences often associated with this disease and its treatment will 
inevitably occur. It is likely that with time and more research, treatments are improving and 
less negative side effects are the result. Further, it is plausible to suggest that with such a 
major emphasis in society on breast cancer diagnosis, treatment, and research, the stigma is 
decreasing. As the general population becomes more aware of and gains more knowledge 
about breast cancer, psychological effects may be less extreme, therefore, helping women to 
find better ways to cope. Additionally, as more women become survivors and share their 
stories, other women can see that they can still be valued and respected, thus helping them to 
adjust more effectively.     
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